They can offer tailored advice to manage these reactions, ensuring your treatment remains comfortable, safe, and effective
Steve Small: And you know, I dont think we do this topic justice on our own, Don
Disclosures: Siham Abdelgani: Nothing to Disclose 883 HBS ISOFORMS AS INNOVATIVE BIOMARKERS IN PREDICTING VIROLOGICAL RESPONSE TO BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA Stefano D'Anna 1 Romina Salpini 1 Elisabetta Degasperi 2 Leonardo Duca 3 Maria Paola Anolli 4 Lorenzo Piermatteo 1 Dana Sambarino 4 Marta Borghi 4 Francesca Ceccherini Silberstein 3 Floriana Facchetti 4 Riccardo Perbellini 4 valentina svicher 1 Pietro Lampertico 5 , 1 Department of Biology, University of Rome Tor Vergata, Rome, Italy, 2 Division of Gastroenterology Foundation IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy, 3 Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy, 4 Foundation IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy, 5 University of Milan Background: HDV exploits HBV surface protein (HBsAg) for its morphogenesis and entry into hepatocytes
Dose titration and your injection schedule GLP-1 therapy never starts at the full dose
Applicable Procedures Codes: J0185, J1434, J1453, J1454, J1456, J1626, J1627, J2405, J2468, J2469, J8501, J8655, J8670, Q0162, Q0166
